(Q54217314)

26 May 2018

title

IMP3 combined with CD44s, a novel predictor for prognosis of patients with hepatocellular carcinoma. (English)

1 reference

26 May 2018

author name string

Shuai Hu

1

1 reference

26 May 2018

Xiaofeng Wu

2

1 reference

26 May 2018

Bo Zhou

3

1 reference

26 May 2018

Zhenchao Xu

4

1 reference

26 May 2018

Jianjie Qin

5

1 reference

26 May 2018

Hao Lu

6

1 reference

26 May 2018

Ling Lv

7

1 reference

26 May 2018

Yun Gao

8

1 reference

26 May 2018

Lei Deng

9

1 reference

26 May 2018

Jie Yin

10

1 reference

26 May 2018

Guoqiang Li

11

1 reference

26 May 2018

publication date

20 March 2014

1 reference

26 May 2018

Journal of Cancer Research and Clinical Oncology

published in

1 reference

26 May 2018

volume

140

1 reference

26 May 2018

issue

6

1 reference

26 May 2018

page(s)

883-893

1 reference

26 May 2018

https://scigraph.springernature.com/pub.10.1007/s00432-014-1639-x

exact match

0 references

cites work

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1639-X

RNA-binding protein insulin-like growth factor II mRNA-binding protein 3 expression promotes tumor invasion and predicts early recurrence and poor prognosis in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1639-X

Analysis of RNA-binding protein IMP3 to predict metastasis and prognosis of renal-cell carcinoma: a retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1639-X

Oncofetal protein IMP3: a novel molecular marker that predicts metastasis of papillary and chromophobe renal cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1639-X

Targeting of CD44 eradicates human acute myeloid leukemic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1639-X

Hepatocellular carcinoma: current management and future development-improved outcomes with surgical resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1639-X

IMP3 is a novel prognostic marker that correlates with colon cancer progression and pathogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1639-X

The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1639-X

Insulin-like growth factor 2 messenger RNA binding protein 3 (IGF2BP3) is a marker of unfavourable prognosis in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1639-X

Expression of the highly conserved RNA binding protein KOC in embryogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1639-X

Hepatocellular carcinoma: review of current treatment with a focus on targeted molecular therapies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1639-X

CD44, a therapeutic target for metastasising tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1639-X

Differentiation of breast cancer stem cells by knockdown of CD44: promising differentiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1639-X

Insulin-like growth factor 2 mRNA binding protein 3 (IGF2BP3) overexpression in pancreatic ductal adenocarcinoma correlates with poor survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1639-X

Targeting CD44-STAT3 signaling by Gemini vitamin D analog leads to inhibition of invasion in basal-like breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1639-X

Molecular targeted therapies in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1639-X

A decade's studies on metastasis of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1639-X

RNA-binding IMPs promote cell adhesion and invadopodia formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1639-X

Insulin-like growth factor II mRNA-binding protein 3 (IMP3) expression in hepatocellular carcinoma. A clinicopathological analysis with emphasis on diagnostic value.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1639-X

IMP3 is a novel biomarker for triple negative invasive mammary carcinoma associated with a more aggressive phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1639-X

Factor VIIa regulates the expression of caspase-3, MMP-9, and CD44 in SW620 colon cancer cells involving PAR2/MAPKs/NF-κB signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1639-X

The involvement of a conserved family of RNA binding proteins in embryonic development and carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1639-X

Diffuse expression of RNA-binding protein IMP3 predicts high-stage lymph node metastasis and poor prognosis in colorectal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1639-X

Overexpression of HnRNP A1 promotes tumor invasion through regulating CD44v6 and indicates poor prognosis for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1639-X

IMP3 predicts aggressive superficial urothelial carcinoma of the bladder

21 January 2018

1 reference

12 December 2020

IMP3 expression is correlated with histologic grade of lung adenocarcinoma

1 reference

12 December 2020

Phase I Trial of sequential administration of recombinant DNA and adenovirus expressing L523S protein in early stage non-small-cell lung cancer

1 reference

12 December 2020

CD44s regulates the TGF-β-mediated mesenchymal phenotype and is associated with poor prognosis in patients with hepatocellular carcinoma

1 reference

12 December 2020

Serum alpha-fetoprotein level per tumor volume reflects prognosis in patients with hepatocellular carcinoma after curative hepatectomy.

1 reference

12 December 2020

Protein expression of CD44 (standard and variant isoforms) in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, p53 expression, and patient survival

1 reference

12 December 2020

IMP-3 is a novel progression marker in malignant melanoma

1 reference

12 December 2020

Oncofetal protein IMP3: a useful diagnostic biomarker for leiomyosarcoma

1 reference

12 December 2020

IGF2BP3 (IMP3) expression is a marker of unfavorable prognosis in ovarian carcinoma of clear cell subtype

1 reference

12 December 2020

10.1007/S00432-014-1639-X

Identifiers

DOI

1 reference

26 May 2018

1 reference

26 May 2018